DWTX•benzinga•
Dogwood Therapeutics Announces The Dosing Of The First Patient In Its Phase 2b Clinical Trial Evaluating Halneuron For The Treatment Of Neuropathic Pain Associated With Prior Chemotherapy Treatment
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 18, 2025 by benzinga